Used in anticancer research due to its structural similarity to paclitaxel, showing potential in inhibiting microtubule depolymerization in tumor cells. Demonstrates cytotoxic activity against certain cancer cell lines, particularly in ovarian and breast cancer models. Investigated for its ability to overcome multidrug resistance in chemotherapy. Also explored as a biosynthetic intermediate for developing novel taxane-based therapeutics with improved solubility and reduced side effects.